T
Thomas H. Connor
Researcher at National Institute for Occupational Safety and Health
Publications - 27
Citations - 1763
Thomas H. Connor is an academic researcher from National Institute for Occupational Safety and Health. The author has contributed to research in topics: Hazardous drugs & Health care. The author has an hindex of 18, co-authored 26 publications receiving 1568 citations. Previous affiliations of Thomas H. Connor include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings
TL;DR: The toxicity of antineoplastic drugs has been well known since they were introduced in the 1940s as mentioned in this paper, and many safety provisions were advanced to reduce worker exposure in the 1980s, but recent studies have shown that workers continue to be exposed to these drugs despite safety policy improvements.
Journal ArticleDOI
Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States.
TL;DR: Substantial levels of contamination from three antineoplastic agents were detected on a variety of surfaces in pharmacy drug preparation areas and drug administration areas in six cancer treatment centers in Canada and the United States.
Journal ArticleDOI
Evaluation of Antineoplastic Drug Exposure of Health Care Workers at Three University-Based US Cancer Centers
Thomas H. Connor,D. Gayle DeBord,Jack R. Pretty,Marc Oliver,Tracy Roth,Peter S.J. Lees,Edward F. Krieg,Bonnie Rogers,Carmen P. Escalante,Christine A. Toennis,John C. Clark,Belinda C. Johnson,Melissa A. McDiarmid +12 more
TL;DR: Despite following recommended safe-handling practices, workplace contamination with antineoplastic drugs in pharmacy and nursing areas continues at these locations.
Journal ArticleDOI
Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies.
Thomas H. Connor,Paul J. M. Sessink,Bruce R. Harrison,Jack R. Pretty,Byron G. Peters,Raul M. Alfaro,Appie Bilos,Gwendolyn Beckmann,Michael R. Bing,Lakisha M. Anderson,Robert DeChristoforo +10 more
TL;DR: Improved decontamination procedures, combined with the use of protective sleeves, reduced the level of platinum contamination by 90%, suggesting that standard decontamin procedures should be reconsidered.
Journal ArticleDOI
Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device
TL;DR: Use of the CSTD significantly reduces surface contamination when preparing cyclophosphamide, ifosfamide, and 5-fluorouracil as compared to standard drug preparation techniques.